Mpox 2022 to 2025 Update: A Comprehensive Review on Its Complications, Transmission, Diagnosis, and Treatment
Viruses · 25.05.2025 · 17 (6) · 753
DOI: 10.3390/v17060753 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 25.05.2025. Verfasst von Rajesh Yadav und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sharda School of Allied Health Sciences, Sharda University, Greater Noida 201310, India. Hauptthemen laut MEDLINE: Mpox, Monkeypox, Monkeypox virus. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU) (grant number IMSUI-DDRSP2501, Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU).
Abstract (Originalsprache)
Monkeypox virus (Mpox virus) is a zoonotic orthopoxvirus that has gained increased global attention due to recent outbreaks. The current review reports the latest update of Mpox cases from 25 February 2022 to 29 April 2025. It also evaluates the possible major complications in human life caused by Mpox. In early 2022, more than 40 countries reported Mpox outbreaks. As of 12 June 2024, the global case count for the 2022–2023 Mpox outbreak was 97,281 confirmed cases, in 118 countries. The World Health Organization (WHO) declared the Mpox virus, a zoonotic disease, a public health emergency of international concern (PHEIC) on 14 August 2024. Mpox symptoms include fever, headache, muscle pain, and face-to-body rashes. The review also highlights Mpox virus replication, genomics, pathology, transmission, diagnosis, and antiviral therapies. The 2022 outbreak is also discussed in detail. The coinfection of HIV in patients infected with Mpox is also discussed. The evolving Mpox epidemiology has raised concerns about the disease’s increasing spread in non-endemic countries, emphasizing the urgent need for control and prevention. The discussion on preventive measures, including vaccination, suggests that cross-protection against Mpox may be possible using orthopoxvirus-specific antibodies. Although there are no specific antiviral drugs available, certain drugs, such as tecovirimat, cidofovir, and ribavirin, are worth considering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sharda School of Allied Health Sciences, Sharda University, Greater Noida 201310, India.
- Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.
- Department of Biotechnology, GLA University, Mathura 281406, India.
- Department of Food Technology, School of Agriculture, Maya Devi University, Dehradun 248011, India.
- South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA.
- Division of Cancer Immunology and Microbiology, Medicine and Oncology Integrated Service Unit, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA.
ORCID-Profile: Rajesh Yadav, Anis Ahmad Chaudhary, Saurabh Gupta, Hassan Ahmed Rudayni, Sanjay Kumar
Förderung
- Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU) (grant number IMSUI-DDRSP2501
- Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU)
Zitieren
APA
Yadav, R., Chaudhary, A. A., Srivastava, U., Gupta, S., Rustagi, S., Rudayni, H. A., Kashyap, V. K., & Kumar, S. (2025). Mpox 2022 to 2025 Update: A Comprehensive Review on Its Complications, Transmission, Diagnosis, and Treatment. Viruses, 17(6), 753. https://doi.org/10.3390/v17060753
Vancouver
Yadav R, Chaudhary AA, Srivastava U, Gupta S, Rustagi S, Rudayni HA, et al. Mpox 2022 to 2025 Update: A Comprehensive Review on Its Complications, Transmission, Diagnosis, and Treatment. Viruses. 2025;17(6):753. doi:10.3390/v17060753
BibTeX
@article{Yadav2025,
author = {Yadav, Rajesh and Chaudhary, Anis Ahmad and Srivastava, Ujjwal and Gupta, Saurabh and Rustagi, Sarvesh and Rudayni, Hassan Ahmed and Kashyap, Vivek Kumar and Kumar, Sanjay},
title = {Mpox 2022 to 2025 Update: A Comprehensive Review on Its Complications, Transmission, Diagnosis, and Treatment},
journal = {Viruses},
year = {2025},
volume = {17},
number = {6},
pages = {753},
doi = {10.3390/v17060753}
}
EUVIMED